Hepatic steatosis improvement by SGLT2is has been linked to the inhibition of serum soluble dipeptidyl peptidase 4 (DPP4) enzyme secreted by hepatocytes and insulin resistance [12]. The gene discussed is DPP4; the disease is Hepatic steatosis.